Needham & Company Reiterates a 'Buy' on LeCroy (LCRY); Solid Q3; Strong Bookings, Continued Healthy Market Conditions Bode Well For Q4 Growth
Tweet
Share
E-mailGet Alerts LCRY Hot Sheet
Price: $14.31 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on LeCroy (NASDAQ: LCRY), PT $17.
Needham analyst says, "LCRY continues to see strong demand in its core oscilloscope business, with FQ3 results coming in above expectations. Orders were strong, with the book to bill remaining above 1.0. The company remains well positioned for continued solid topline growth, with a strong new product lineup and an active R&D roadmap for F12. LCRY remains one of the most inexpensive micro-cap names in our universe. We believe the shares will be accorded a higher multiple as management continues to execute on the business model...We are lowering our FQ4 non-GAAP EPS estimate to $0.27 from $0.33 on revenues of $47M, up from our prior $46.5M estimate. We are trimming our F12 non-GAAP EPS estimate to $1.16 from $1.20 on revenues of $195M."
For more ratings news on LeCroy click here and for the rating history of LeCroy click here.
Shares of LeCroy closed at $13.31 yesterday.
Needham analyst says, "LCRY continues to see strong demand in its core oscilloscope business, with FQ3 results coming in above expectations. Orders were strong, with the book to bill remaining above 1.0. The company remains well positioned for continued solid topline growth, with a strong new product lineup and an active R&D roadmap for F12. LCRY remains one of the most inexpensive micro-cap names in our universe. We believe the shares will be accorded a higher multiple as management continues to execute on the business model...We are lowering our FQ4 non-GAAP EPS estimate to $0.27 from $0.33 on revenues of $47M, up from our prior $46.5M estimate. We are trimming our F12 non-GAAP EPS estimate to $1.16 from $1.20 on revenues of $195M."
For more ratings news on LeCroy click here and for the rating history of LeCroy click here.
Shares of LeCroy closed at $13.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
